First-of-Kind Rapid Pregnancy Blood Test Cleared by FDA

Abbott announced that the Food and Drug Administration (FDA) has granted clearance for the i-STAT Total β-hCG blood test to detect if a woman is in the early stages of pregnancy.

This first-of-its-kind blood test is designed for use with the handheld, portable i-STAT System blood analyzer to rapidly detect human chorionic gonadotropin (hCG) hormone, which is usually used to determine whether a woman is pregnant. The test can measure very low levels of hCG in whole blood or plasma with only 2–3 drops of blood to provide high-quality results within 10 minutes.

The i-STAT Total β-hCG blood test can be used in a range of situations, including emergency settings, to guide decision-making by clinicians on medications, imaging, surgery, and other medical care.

For more information visit Abbott.com.

Want to read more?